1. Von Willebrand factor: molecular size and functional activity

   • M. Furlan

   REVIEW ARTICLE Pages: 341 - 348

2. Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study

   • J. Thaler
   • G. Gastl
   • Austrian Biological Response Modifier (BRM) Study Group*

   ORIGINAL ARTICLE Pages: 349 - 355

3. Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients

   • F. Cervantes
   • J. Briones
   • E. Montserrat

   ORIGINAL ARTICLE Pages: 357 - 360

4. Assessment of the composition of bone marrow prior to and following autologous BMT and PBSCT by magnetic resonance

   • F. Schick
   • H. Einsele
   • C. D. Claussen

   ORIGINAL ARTICLE Pages: 361 - 370

5. A long-lasting, complete hematologic and cytogenetic remission of chronic myelogenous leukemia after treatment with busulfan alone

   • C. M. P. W. Mandigers
   • E. J. B. M. Mensink
   • T. de Witte

   CASE REPORT Pages: 371 - 373

6. Co-expression of two FAB-specific chromosome changes, t(15; 17) and t(8; 21), in a case of acute promyelocytic leukemia

   • A. Movafagh
   • N. Varma
   • S. Varma

   CASE REPORT Pages: 375 - 377

7. Radiotherapy combined with erythropoietin for the treatment of extramedullary hematopoiesis in an alloimmunized patient with thalassemia intermedia

   • P. Cianciulli
   • F. Sorrentino
   • S. Amadori

   CASE REPORT Pages: 379 - 381

8. Acquired C 1-inhibitor deficiency with angioedema due to pleomorphic immunocytoma in a patient with three malignant tumors: long-term follow-up data and presentation of an additional case

   • W. Bohle
   • U. Rüther
   • P. Jipp

   CASE REPORT Pages: 383 - 386